The Safety and Efficacy of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy

ABSTRACT: Evaluation of the histologically proven adenoma and carcinoma detection rate in patients undergoing a full colonoscopy with and without mucosal contrast enhancement, obtained with 200 mg of Methylene Blue MMX tablets.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms,Polyp And Adenoma Detection During Colonoscopy

PROVIDER: 2132669 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR